Published date: 8 September 2023
Closed early engagement
Contract summary
Industry
Medical equipments, pharmaceuticals and personal care products - 33000000
Pharmaceutical products - 33600000
Various medicinal products - 33690000
Medical solutions - 33692000
Infusion solutions - 33692100
Parenteral nutrition products - 33692200
Parenteral feeding solutions - 33692210
Enteral feeds - 33692300
Injectable solutions - 33692500
Intravenous fluids - 33692510
Pharmacy services - 85149000
Location of contract
SE1 9RT
Procurement reference
CF-1839400D0O000000rwimUAA
Published date
8 September 2023
Closing date
12 October 2023
Contract type
Service contract
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The Trust has a requirement for controlled environments for the preparation of high-risk
injectable medicines into ready-to-administer (RtA) formats for patients. Aseptic facilities
are also required for the manufacture of Advanced Therapy medicines including gene, cell
and viral therapies, and a growing number of Investigational Medicinal Products used in
clinical trials.
More information
Attachments
-
- GSTT Aseptic Services Prior Information Notice and Pre-Market Engagement Questionnairev1.0.docx
- GSTT Aseptic Services Prior Information Notice and Pre-Market Engagement Questionnairev1.0
About the buyer
Contact name
Kemi Ore
Address
Great Maze Pond
London
SE1 9RT
GB
Telephone
+44 20 71887188
Share this notice
Closing date: 12 October 2023